The present invention relates generally to the field of lens design. More particularly, the present invention relates to a system, method, and apparatus for using a library of computer eye models to design and test intraocular lenses (IOLs) for improved peripheral and/or central visual field performance.
Intraocular Lenses (IOLs) may be used for restoring visual performance after a cataract or other ophthalmic procedure in which the natural crystalline lens is replaced with or supplemented by implantation of an IOL. When the optics of the eye are changed by such a procedure, the goal is to improve vision in the central field. However, current IOL technology degrades peripheral optical quality, which is known to degrade peripheral visual performance. Degraded peripheral vision may be detrimental to many aspects of life, including increased risks for car crashes and falling.
One of the problems when looking for an optimal solution to correct peripheral aberrations is that peripheral aberrations are strongly dependent on the anterior corneal geometry and axial lengths (and therefore, on the foveal refractive state). Due to that, any design to correct peripheral aberration will perform differently depending on the foveal refractive state, corneal anterior geometry and axial lengths (anterior chamber depth and vitreous length).
Different eye models have been proposed to evaluate pre-clinically IOLs visual performance on axis and to design new IOLs based on the on-axis performance. However, these eye models usually have a fixed cornea and modify vitreous lengths to test IOLs with different optical powers. Also, these average eye models have not been used to test the periphery.
Thus, there is a need for new types of computer eye models to evaluate IOL performance. There is a further need for improved computer eye models to design new IOLs based on on-axis performance. There is an additional need for improved system, method, and apparatus for a library of computer eye models to design and test intraocular lenses (IOLs) that improve peripheral and central visual field performance, and to test the central and peripheral optical performance of new and existing IOL designs under more realistic conditions. There is a need for eye models that contain higher order cornea aberrations and different biometry and are validated for a large field of view (from +30 to −30 degrees of the visual field). The present invention satisfies these needs and provides other related advantages.
The various present embodiments now will be discussed in detail with an emphasis on highlighting the advantageous features with reference to the drawings of various embodiments. The illustrated embodiments are intended to illustrate, but not to limit the invention. These drawings include the following figures, in which like numerals indicate like parts:
The following detailed description describes the present embodiments, with reference to the accompanying drawings. In the drawings, reference numbers label elements of the present embodiments. These reference numbers are reproduced below in connection with the discussion of the corresponding drawing features.
It is to be understood that the figures and descriptions of the present invention have been simplified to illustrate elements that are relevant for a clear understanding of the present invention, while eliminating, for the purpose of clarity, many other elements found in typical lenses, lens systems and lens design methods. Those of ordinary skill in the pertinent arts may recognize that other elements and/or steps are desirable and/or required in implementing the present invention. However, because such elements and steps are well known in the art, and because they do not facilitate a better understanding of the present invention, a discussion of such elements and steps is not provided herein. The disclosure herein is directed to all such variations and modifications to such elements and methods known to those skilled in the pertinent arts.
For normal patients (e.g., uncomplicated cataract patients), it is desirable to balance peripheral vision with good central vision in order to maximize overall functional vision. For those patients having a pathological loss of central vision, peripheral vision may be maximized, taking into account the visual angle where the retina is healthy. It is also understood that embodiments may be applied directly, or indirectly, to various IOLs including, for example, phakic IOLs and piggyback IOLs, as well as other types of ophthalmic lenses including, but not limited to, corneal implants, corneal surgical procedures such as LASIK or PRK, contact lenses, and other such devices. In some embodiments, various types of ophthalmic devices are combined, for example, an intraocular lens and a LASIK procedure may be used together to provide a predetermined visual outcome. Embodiments of the invention may also find particular use with spherical, aspheric, multifocal or accommodating intraocular lenses.
The present invention is directed to a library of computer eye models to design intraocular lenses (IOIs) that improve peripheral and central visual field performance, and to test the central and peripheral optical performance of new and existing IOL designs under more realistic conditions. In addition, the eye model(s) may also be used to design IOIs and other ophthalmic lenses, such as a phakic IOL or a corneal implant, and other vision correction methodologies, such as laser treatments, and a system and method relating to same, for providing improved peripheral and central visual field performance, and to test the central and peripheral optical performance of new and existing IOL designs under more realistic conditions.
The apparatus, system and method of the present invention may be predictive as to the performance of IOLs in the eye under any of a variety of circumstances, and with respect to any of a variety of ocular conditions and eye types, and may provide for improved performance of IOIs. For example, the present invention may include mathematical modeling of certain characterizations of the eye, such as total axial length of the eye (AL), cornea thickness (CT), anterior chamber depth (ACD), elevation map of the anterior cornea (Zemike Fit) and/or IOL Power, and comparison of model output to actual clinical data. It will be appreciated by those of ordinary skill in the pertinent arts that the apparatus, system and method of the present invention may be embodied in one or more computing processors, associated with one or more computing memories, within which is resident computing code to execute the mathematical models discussed herein, to provide the eye models discussed herein in a relational database to design and test ophthalmic lenses as part of the system, apparatus and method of the present invention. Further, those skilled in the art will appreciate, in light of the disclosure herein, that the aspects of the present invention may be provided to the one or more computing processors for processing via one or more computing networks, including via one or more nodes of a computing network. Computing networks for use in the present invention may include the Internet, an intranet, an extranet, a cellular network, a satellite network, a fiber optic network, or the like. Those skilled in the art might appreciate that all relevant measurements on what the present invention is based may be performed by using instruments known in the art. However, an instrument comprising all needed measurements (ocular and corneal wavefront aberration measurements) as well as the needed calculations to test and design IOLs can be considered an apparatus of the present invention.
An instrument can comprise a set of apparatuses, including a set of apparatuses from different manufacturers, configured to perform the necessary measurements and calculations.
The processor 104 may be embodied in a general purpose desktop, laptop, tablet or mobile computer, and/or may comprise hardware and/or software associated with inputs 102. In certain embodiments, the system 100 may be configured to be electronically coupled to another device, such as one or more instruments for obtaining measurements of an eye or a plurality of eyes. Alternatively, the system 100 may be adapted to be electronically and/or wirelessly coupled to one or more other devices.
The system 100 can be adapted for designing and evaluating intraocular lenses for a large field of view, comprising: a plurality of eye models based upon a first intraocular lens, associated with at least one processor 104, where each eye model of the plurality of eye models includes at least one aberration. A simulator provided by the at least one processor 104 that models a second intraocular lens in at least one of the plurality of eye models, where the simulator outputs at least one aberration of the second intraocular lens in the at least one of said plurality of eye models. A comparator instantiated by the at least one processor 104 compares differences between the aberrations of the first intraocular lens and the second intraocular lens.
The capsular bag 28 is a resilient material that changes the shape and/or location of natural lens 26 in response to ocular forces produced when ciliary muscles 36 contract and stretch the natural lens 26 via zonules 38 disposed about an equatorial region of the capsular bag 28. This shape change may flatten the natural lens 26, thereby producing a relatively low optical power for providing distant vision in an emmetropic eye. To produce intermediate and/or near vision, ciliary muscles 36 contract, thereby relieving tension on the zonules 38. The resiliency of the capsular bag 28 thus provides an ocular force to reshape the natural lens 26 to modify curvature to provide an optical power suitable for required vision. This change, or “accommodation,” is achieved by changing the shape of the crystalline lens. Accommodation, as used herein, includes the making of a change in the focus of the eye for different distances.
Light enters the eye 20 from the left of
The anterior chamber 30 is filled with aqueous humor, and optically communicates through the lens 26 with the vitreous or posterior chamber 32, which occupies the posterior % or so of the eyeball and is filled with vitreous humor. The average adult eye has an ACD of about 3.15 mm, although the ACD typically shallows by about 0.01 mm per year. Further, the ACD is dependent on the accommodative state of the lens 26 (i.e., whether the lens 26 is focusing on an object that is near or far).
The terms “power” or “optical power” are used herein to indicate the ability of a lens, an optic, an optical surface, or at least a portion of an optical surface, to redirect incident light for the purpose of forming a real or virtual focal point. Optical power may result from reflection, refraction, diffraction, or some combination thereof and is generally expressed in units of Diopters. One of skill in the art will appreciate that the optical power of a surface, lens, or optic is generally equal to the reciprocal of the focal length of the surface, lens, or optic, when the focal length is expressed in units of meters.
The term “near vision,” as used herein, refers to vision provided by at least a portion of a lens 26 or an IOL 50, wherein objects relatively close to the subject are substantially in focus on the retina of the subject eye. The term “near vision” generally corresponds to the vision provided when objects are at a distance from the subject eye of between about 25 cm to about 50 cm. The term “distance vision” or “far vision,” as used herein, refers to vision provided by at least a portion of the lens 26 or IOL 50, wherein objects relatively far from the subject are substantially in focus on the retina of the eye. The term “distance vision” generally corresponds to the vision provided when objects are at a distance of at least about 2 m or greater. The term “intermediate vision,” as used herein, refers to vision provided by at least a portion of a lens, wherein objects at an intermediate distance from the subject are substantially in focus on the retina of the eye. Intermediate vision generally corresponds to vision provided when objects are at a distance of about 2 m to about 50 cm from the subject eye. The term “peripheral vision,” as used herein, refers to vision outside the central visual field.
A library of computer eye models is created to design new IOLs that improve peripheral and central visual field performance. These computer eye models are also used to test the central and peripheral optical performance of new and existing IOL designs under more realistic conditions. Elements of an eye model include anterior surface of the cornea (based on biometry data with topography data fitted to Zernike polynomials for a 6 mm central zone), posterior surface of the cornea, anterior lens (defined by IOL power), posterior lens (defined by IOL power), and the retina. These computer eye models are based on the following distances: total axial length (AL) (based on biometry data); cornea thickness (CT) (based on biometry data); anterior chamber depth (ACD) (optimized using the post-operative refraction); and lens thickness (LT) (defined by the IOL power). These eye models also include constant values and customized values. The constant values (i.e., similar for all eyes) include the posterior cornea and the retina 22. The customized values (i.e., different for each eye model) include the anterior cornea, and the anterior and posterior surfaces of the lens or lenses for dual optic systems.
A process to create an eye model starts with standard eye model data (“standard” in the sense that the particular values are similar for all eye models) in combination with biometry data and IOL power of an implanted IOL. The standard eye model is calculated based on data relating to posterior cornea geometry, retina geometry, and iris position (i.e., constant values that are similar for all eye models). The biometry data (i.e., customized values that are different for each eye model) is calculated based upon data relating to anterior cornea geometry, axial length AL, and cornea thickness CT. The implanted IOL power (i.e., customized values that are different for each eye model) is calculated based upon anterior lens geometry, posterior lens geometry, and lens thickness LT. The implanted IOL power of the patient is known. If the power is not accurate after the procedure, it is assumed that the person is correctly refracted by wearing spectacles to correct for on-axis errors. Thus, the power on-axis is set to zero, and the peripheral refractive power has the value added or subtracted accordingly.
By way of non-limiting example, the embodiments herein are based on data from eleven (11) patients. Each patient has a particular eye model based on patient and existing biometries. For the eleven patients, eleven different eye models are created. For each of the eleven different eye models, a particular IOL design is “plugged in,” and that same specific IOL design is tested at various diopters (e.g., 17.5, 19.5, 22, 23, etc.). Each power generates an output (e.g., a refractive error). A database is created that includes each eye model with the simulated outcomes provided by the particular IOL design. A database can be built-up to include as many eye models as desired. In this manner, one can review the results obtained from one lens design over a range of powers to see how that particular lens design behaves in a population. Then, a new IOL design may be plugged in and can compared to the prior IOL design. In this manner, feedback is provided to obtain data showing which specific IOL design provides the best result for an eye having particular biometries.
As seen in the illustrative examples of
The computer eye models provide a range of IOL powers tested between 19 and 24 Diopters (D) and each eye model is described by the following biometric parameters: total axial length of the eye (AL); cornea thickness (CT); anterior chamber depth (ACD); elevation map of the anterior cornea (Zernike Fit); and IOL Power. The foregoing information is used to create the eye models using ray tracing software (e.g., ZEMAX). All surfaces are centered with respect to the optical axis OA. As used herein, a ray tracing procedure is a procedure that simulates light propagation and refraction, by means of an exact solution of Snell's law, for all rays passing through an optical system. Those skilled in the art will appreciate that, for example, a ZEMAX optical design software simulation may be employed in order to provide ray tracing modeling for various aberrations of a realistic computer eye model. ZEMAX optical analysis software is manufactured by ZEMAX, LLC. This and other known optical modeling techniques, including Code V, OSLO, ASAP, and other software may also be used to create eye models. An example of an eye modeling in ZEMAX is shown in
The above-mentioned eleven eye models can be associated with the processor 104, with a simulator (not shown) providing the input 102, as seen in
In a specific illustration, the realistic eye models herein presented can be used to estimate the optical performance of different IOLs at the periphery. For example,
This library of realistic eye models can be also used to evaluate new IOL designs at the periphery.
Simulations showed that the new IOL can reduce M and J0 at the periphery without modifying J45 and vertical coma. Simulations also shows that there is a minimal increment in SA and an increment in horizontal coma that has opposite sign that the one induced by the spherical lens.
There may be additional alternative embodiments. For example, the designed eye models can also include the different axes of the eye, incorporating the shift of the fovea relative to the cornea, pupil and IOL. In another example, the eye models can be used to predict chromatic properties, including longitudinal chromatic aberrations, chromatic shift of aberrations and transverse chromatic aberrations. In a further example, the eye models can simulate a realistic range of pupillary conditions. The eye models can include changes that happen when the eyes converge (e.g. pupillary shift).
In the alternative, the schematic eye models herein proposed can be used to test any existing IOL design (e.g., monofocal, multifocal, extended range of vision, or the like) and to optimize new ones. In another alternative, the schematic eye models herein proposed can be used to test corneal refractive procedures, add on lenses or spectacles. As mentioned, the schematic eye models herein proposed can be used for ray tracing simulations. The geometry of the schematic eye models herein proposed can be used to build physical eye models. The schematic eye models could also be used to predict on-axis VA and peripheral CS. The method described herein can be used to customize lens design for any patient.
Needless to say the illustrations immediately hereinabove are provided by way of example only, and may be applicable to lens design, modification of physical lens design, modification to simulation, modification to selections of eye models, and the like. Similarly, the illustrations are applicable to not only groups of patients, or with regard to current lens designs, but is equally applicable to custom and quasi-custom lens design, for individual patients and limited or unique subsets of patients, respectively.
In addition, the claimed invention is not limited in size and may be constructed in various sizes in which the same or similar principles of operation as described above would apply. Furthermore, the figures (and various components shown therein) of the specification are not to be construed as drawn to scale.
Throughout this specification the word “comprise”, or variations such as “comprises” or “comprising”, will be understood to imply the inclusion of a stated element, integer or step, or group of elements, integers or steps, but not the exclusion of any other element, integer or step, or group of elements, integers or steps.
The use of the expression “at least” or “at least one” suggests the use of one or more elements or ingredients or quantities, as the use may be in the embodiment of the disclosure to achieve one or more of the desired objects or results.
The numerical values mentioned for the various physical parameters, dimensions or quantities are only approximations and it is envisaged that the values higher/lower than the numerical values assigned to the parameters, dimensions or quantities fall within the scope of the disclosure, unless there is a statement in the specification specific to the contrary.
The terminology used herein is for the purpose of describing particular example embodiments only and is not intended to be limiting. As used herein, the singular forms “a”, “an” and “the” may be intended to include the plural forms as well, unless the context clearly indicates otherwise. The terms “comprises,” “comprising,” “including,” and “having,” are inclusive and therefore specify the presence of stated features, integers, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, integers, steps, operations, elements, components, and/or groups thereof. The method steps, processes, and operations described herein are not to be construed as necessarily requiring their performance in the particular order discussed or illustrated, unless specifically identified as an order of performance. It is also to be understood that additional or alternative steps may be employed.
When an element or layer is referred to as being “on”, “engaged to”, “connected to” or “coupled to” another element or layer, it may be directly on, engaged, connected or coupled to the other element or layer, or intervening elements or layers may be present. In contrast, when an element is referred to as being “directly on,” “directly engaged to”, “directly connected to” or “directly coupled to” another element or layer, there may be no intervening elements or layers present. Other words used to describe the relationship between elements should be interpreted in a like fashion (e.g., “between” versus “directly between,” “adjacent” versus “directly adjacent,” etc.). As used herein, the term “and/or” includes any and all combinations of one or more of the associated listed items.
Spatially relative terms, such as “front,” “rear,” “left,” “right,” “inner,” “outer,” “beneath”, “below”, “lower”, “above”, “upper”, “horizontal”, “vertical”, “lateral”, “longitudinal” and the like, may be used herein for ease of description to describe one element or feature's relationship to another element(s) or feature(s) as illustrated in the figures. Spatially relative terms may be intended to encompass different orientations of the device in use or operation in addition to the orientation depicted in the figures. For example, if the device in the figures is turned over, elements described as “below” or “beneath” other elements or features would then be oriented “above” the other elements or features. Thus, the example term “below” can encompass both an orientation of above and below. The device may be otherwise oriented (rotated 90 degrees or at other orientations) and the spatially relative descriptors used herein interpreted accordingly.
The above description presents the best mode contemplated for carrying out the present invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains to make and use this invention. This invention is, however, susceptible to modifications and alternate constructions from that discussed above that are fully equivalent. Moreover, features described in connection with one embodiment of the invention may be used in conjunction with other embodiments, even if not explicitly stated above. Consequently, this invention is not limited to the particular embodiments disclosed. On the contrary, this invention covers all modifications and alternate constructions coming within the spirit and scope of the invention as generally expressed by the following claims, which particularly point out and distinctly claim the subject matter of the invention.
This application claims priority to, and the benefit of, under U.S.C. § 119(e) of U.S. Provisional Appl. No. 62/412,738, filed on Oct. 25, 2016, which is incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
2077092 | Broder | Apr 1937 | A |
3305294 | Alvarez | Feb 1967 | A |
3367734 | Karl et al. | Feb 1968 | A |
3735685 | Plummer | May 1973 | A |
4010496 | Neefe | Mar 1977 | A |
4056311 | Winthrop et al. | Nov 1977 | A |
4077071 | Freeman | Mar 1978 | A |
4093361 | Erickson et al. | Jun 1978 | A |
4134160 | Bayers | Jan 1979 | A |
4162122 | Cohen | Jul 1979 | A |
4174543 | Kelman | Nov 1979 | A |
4210391 | Cohen et al. | Jul 1980 | A |
4249272 | Poler | Feb 1981 | A |
4254509 | Tennant | Mar 1981 | A |
4254510 | Tennant | Mar 1981 | A |
4316293 | Bayers | Feb 1982 | A |
4319564 | Karickhoff | Mar 1982 | A |
4338005 | Cohen | Jul 1982 | A |
4340283 | Cohen et al. | Jul 1982 | A |
4370760 | Kelman | Feb 1983 | A |
4377873 | Reichert | Mar 1983 | A |
4402579 | Poler | Sep 1983 | A |
4403353 | Tennant | Sep 1983 | A |
4404694 | Kelman | Sep 1983 | A |
4409691 | Levy | Oct 1983 | A |
4424597 | Schlegel | Jan 1984 | A |
4437733 | Takahashi et al. | Mar 1984 | A |
4446581 | Blake | May 1984 | A |
4480340 | Shepard | Nov 1984 | A |
4500382 | Foster | Feb 1985 | A |
4504982 | Burk | Mar 1985 | A |
4551864 | Akhavi | Nov 1985 | A |
4556998 | Siepser | Dec 1985 | A |
4560383 | Leiske | Dec 1985 | A |
4605409 | Kelman | Aug 1986 | A |
4605411 | Fedorov et al. | Aug 1986 | A |
4629460 | Dyer | Dec 1986 | A |
4629462 | Feaster | Dec 1986 | A |
4637697 | Freeman | Jan 1987 | A |
4642112 | Freeman | Feb 1987 | A |
4655565 | Freeman | Apr 1987 | A |
4665913 | L'Esperance, Jr. | May 1987 | A |
4669466 | L'Esperance | Jun 1987 | A |
4673406 | Schlegel | Jun 1987 | A |
4676791 | Lemaster et al. | Jun 1987 | A |
4676792 | Praeger | Jun 1987 | A |
4681102 | Bartell | Jul 1987 | A |
4687484 | Kaplan | Aug 1987 | A |
4687485 | Lim et al. | Aug 1987 | A |
RE32525 | Pannu | Oct 1987 | E |
4725277 | Bissonette | Feb 1988 | A |
4732148 | L'Esperance, Jr. | Mar 1988 | A |
4734095 | Siepser | Mar 1988 | A |
4764930 | Bille et al. | Aug 1988 | A |
4770172 | L'Esperance, Jr. | Sep 1988 | A |
4773414 | L'Esperance, Jr. | Sep 1988 | A |
4778462 | Grendahl | Oct 1988 | A |
4781717 | Grendahl | Nov 1988 | A |
4787903 | Grendahl | Nov 1988 | A |
4787904 | Severin et al. | Nov 1988 | A |
4795462 | Grendahl | Jan 1989 | A |
4798608 | Grendahl | Jan 1989 | A |
4798609 | Grendahl | Jan 1989 | A |
4828558 | Kelman | May 1989 | A |
4834748 | McDonald | May 1989 | A |
4863261 | Flammer | Sep 1989 | A |
4863539 | Lee et al. | Sep 1989 | A |
4898461 | Portney | Feb 1990 | A |
4932970 | Portney | Jun 1990 | A |
4995714 | Cohen | Feb 1991 | A |
4995715 | Cohen | Feb 1991 | A |
4997442 | Barrett | Mar 1991 | A |
5016977 | Baude et al. | May 1991 | A |
5019097 | Knight et al. | May 1991 | A |
5042938 | Shimozono | Aug 1991 | A |
5047052 | Dubroff | Sep 1991 | A |
5054905 | Cohen | Oct 1991 | A |
5056908 | Cohen | Oct 1991 | A |
5066301 | Wiley | Nov 1991 | A |
5071432 | Baikoff | Dec 1991 | A |
5078742 | Dahan | Jan 1992 | A |
5089023 | Swanson | Feb 1992 | A |
5096285 | Silberman | Mar 1992 | A |
5108388 | Trokel et al. | Apr 1992 | A |
5114220 | Baude et al. | May 1992 | A |
5117306 | Cohen | May 1992 | A |
5120120 | Cohen | Jun 1992 | A |
5121979 | Cohen | Jun 1992 | A |
5121980 | Cohen | Jun 1992 | A |
5133749 | Nordan | Jul 1992 | A |
5144483 | Cohen | Sep 1992 | A |
5147395 | Willis | Sep 1992 | A |
5147397 | Christ et al. | Sep 1992 | A |
5163934 | Munnerlyn | Nov 1992 | A |
5173723 | Volk et al. | Dec 1992 | A |
5184405 | Cress | Feb 1993 | A |
5197981 | Southard | Mar 1993 | A |
5201763 | Brady et al. | Apr 1993 | A |
5203790 | McDonald | Apr 1993 | A |
5207668 | L'Esperance, Jr. | May 1993 | A |
5217491 | Vanderbilt | Jun 1993 | A |
5219343 | L'Esperance, Jr. | Jun 1993 | A |
5225858 | Portney | Jul 1993 | A |
5229797 | Futhey et al. | Jul 1993 | A |
5258025 | Fedorov et al. | Nov 1993 | A |
5278592 | Marie et al. | Jan 1994 | A |
5379110 | Matsui et al. | Jan 1995 | A |
5408281 | Zhang | Apr 1995 | A |
5433745 | Graham et al. | Jul 1995 | A |
5476513 | Brady et al. | Dec 1995 | A |
5479220 | Komatsu et al. | Dec 1995 | A |
5567365 | Weinschenk, III et al. | Oct 1996 | A |
5571177 | Deacon et al. | Nov 1996 | A |
5620720 | Glick et al. | Apr 1997 | A |
5628796 | Suzuki | May 1997 | A |
5646791 | Glockler | Jul 1997 | A |
5652638 | Roffman et al. | Jul 1997 | A |
5652640 | Schneider et al. | Jul 1997 | A |
5691800 | Iki et al. | Nov 1997 | A |
5699142 | Lee et al. | Dec 1997 | A |
5716403 | Tran et al. | Feb 1998 | A |
5748282 | Freeman | May 1998 | A |
5760871 | Kosoburd et al. | Jun 1998 | A |
5796462 | Roffman et al. | Aug 1998 | A |
5801807 | Satake et al. | Sep 1998 | A |
5928282 | Nigam | Jul 1999 | A |
5968094 | Werblin et al. | Oct 1999 | A |
5993438 | Juhasz et al. | Nov 1999 | A |
6015435 | Valunin et al. | Jan 2000 | A |
6051024 | Cumming | Apr 2000 | A |
6126283 | Wen et al. | Oct 2000 | A |
6126286 | Portney | Oct 2000 | A |
6129759 | Chambers | Oct 2000 | A |
6142625 | Sawano et al. | Nov 2000 | A |
6179870 | Sourdille et al. | Jan 2001 | B1 |
6210005 | Portney | Apr 2001 | B1 |
6235055 | Chu | May 2001 | B1 |
6241356 | Von Wallfeld et al. | Jun 2001 | B1 |
6261321 | Kellan | Jul 2001 | B1 |
6319282 | Nishi | Nov 2001 | B1 |
6338559 | Williams et al. | Jan 2002 | B1 |
6419697 | Kelman | Jul 2002 | B1 |
6457826 | Lett | Oct 2002 | B1 |
6460997 | Frey et al. | Oct 2002 | B1 |
6464355 | Gil | Oct 2002 | B1 |
6474814 | Griffin | Nov 2002 | B1 |
6488708 | Sarfarazi | Dec 2002 | B2 |
6491721 | Freeman et al. | Dec 2002 | B2 |
6497483 | Frey et al. | Dec 2002 | B2 |
6527389 | Portney | Mar 2003 | B2 |
6533416 | Fermigier et al. | Mar 2003 | B1 |
6536899 | Fiala | Mar 2003 | B1 |
6537317 | Steinert et al. | Mar 2003 | B1 |
6547822 | Lang | Apr 2003 | B1 |
6550917 | Neal et al. | Apr 2003 | B1 |
6554859 | Lang et al. | Apr 2003 | B1 |
6557992 | Dwyer et al. | May 2003 | B1 |
6575572 | Lai et al. | Jun 2003 | B2 |
6598606 | Terwee et al. | Jul 2003 | B2 |
6609793 | Norrby et al. | Aug 2003 | B2 |
6705729 | Piers et al. | Mar 2004 | B2 |
6786603 | Altmann | Sep 2004 | B2 |
6802605 | Cox et al. | Oct 2004 | B2 |
6808262 | Chapoy et al. | Oct 2004 | B2 |
6817714 | Altmann | Nov 2004 | B2 |
6830332 | Piers et al. | Dec 2004 | B2 |
6846326 | Zadno-Azizi et al. | Jan 2005 | B2 |
6851803 | Wooley et al. | Feb 2005 | B2 |
6899425 | Roffman et al. | May 2005 | B2 |
6923539 | Simpson et al. | Aug 2005 | B2 |
6923540 | Ye et al. | Aug 2005 | B2 |
6986578 | Jones | Jan 2006 | B2 |
7036931 | Lindacher et al. | May 2006 | B2 |
7048760 | Cumming | May 2006 | B2 |
7061693 | Zalevsky | Jun 2006 | B2 |
7073906 | Portney | Jul 2006 | B1 |
7137702 | Piers et al. | Nov 2006 | B2 |
7156516 | Morris et al. | Jan 2007 | B2 |
7188949 | Bandhauer et al. | Mar 2007 | B2 |
7281797 | Yamaguchi et al. | Oct 2007 | B2 |
7287852 | Fiala | Oct 2007 | B2 |
7293873 | Dai et al. | Nov 2007 | B2 |
7296893 | Dai | Nov 2007 | B2 |
7339539 | Joannopoulos et al. | Mar 2008 | B2 |
7350916 | Hong et al. | Apr 2008 | B2 |
7365917 | Zalevsky | Apr 2008 | B2 |
7377640 | Piers et al. | May 2008 | B2 |
7425068 | Koest | Sep 2008 | B2 |
7441894 | Zhang et al. | Oct 2008 | B2 |
7455404 | Bandhauer et al. | Nov 2008 | B2 |
7455407 | Neal et al. | Nov 2008 | B2 |
7475986 | Dai et al. | Jan 2009 | B2 |
7547102 | Dai | Jun 2009 | B2 |
7615073 | Deacon et al. | Nov 2009 | B2 |
7616330 | Neal et al. | Nov 2009 | B2 |
7659971 | Warden et al. | Feb 2010 | B2 |
7726813 | Dai | Jun 2010 | B2 |
7784946 | Leblanc | Aug 2010 | B2 |
7794497 | Brady et al. | Sep 2010 | B2 |
7857451 | Thibos et al. | Dec 2010 | B2 |
7871162 | Weeber | Jan 2011 | B2 |
7911211 | Crain et al. | Mar 2011 | B2 |
7931371 | Dai | Apr 2011 | B2 |
7931374 | Dai et al. | Apr 2011 | B2 |
7938538 | Lu et al. | May 2011 | B2 |
7944553 | Simpson et al. | May 2011 | B1 |
7969585 | Neal et al. | Jun 2011 | B2 |
8123357 | Dai et al. | Feb 2012 | B2 |
8382281 | Weeber | Feb 2013 | B2 |
8480228 | Weeber | Jul 2013 | B2 |
8596787 | Dai | Dec 2013 | B2 |
8657445 | Olsen | Feb 2014 | B2 |
8696119 | Van Der Mooren et al. | Apr 2014 | B2 |
8740382 | Liu et al. | Jun 2014 | B1 |
8746882 | Vidal et al. | Jun 2014 | B2 |
8764822 | Harris et al. | Jul 2014 | B2 |
8862447 | Weeber | Oct 2014 | B2 |
9211061 | Kasthurirangan et al. | Dec 2015 | B2 |
9241627 | Steinmueller | Jan 2016 | B2 |
9393108 | Canovas Vidal et al. | Jul 2016 | B2 |
9491431 | Zhou | Nov 2016 | B2 |
9700201 | Bex et al. | Jul 2017 | B2 |
20010051825 | Peterson | Dec 2001 | A1 |
20020118337 | Perrott et al. | Aug 2002 | A1 |
20020173846 | Blake et al. | Nov 2002 | A1 |
20020196408 | Bhalakia et al. | Dec 2002 | A1 |
20020196412 | Abitbol | Dec 2002 | A1 |
20030033013 | Callahan et al. | Feb 2003 | A1 |
20030053025 | Turner et al. | Mar 2003 | A1 |
20030076478 | Cox | Apr 2003 | A1 |
20030163122 | Sumiya | Aug 2003 | A1 |
20030171808 | Phillips | Sep 2003 | A1 |
20030189690 | Mihashi et al. | Oct 2003 | A1 |
20040021824 | Ye et al. | Feb 2004 | A1 |
20040021825 | Richardson | Feb 2004 | A1 |
20040054358 | Cox | Mar 2004 | A1 |
20040057010 | Altmann | Mar 2004 | A1 |
20040068317 | Knight | Apr 2004 | A1 |
20040085515 | Roffman et al. | May 2004 | A1 |
20040106992 | Lang et al. | Jun 2004 | A1 |
20040111153 | Woods et al. | Jun 2004 | A1 |
20040150789 | Jones | Aug 2004 | A1 |
20040156014 | Piers et al. | Aug 2004 | A1 |
20040167622 | Sunalp et al. | Aug 2004 | A1 |
20040183997 | Suzuki | Sep 2004 | A1 |
20040230299 | Simpson et al. | Nov 2004 | A1 |
20040260275 | Liang et al. | Dec 2004 | A1 |
20050024647 | Montgomery | Feb 2005 | A1 |
20050096226 | Stock et al. | May 2005 | A1 |
20050122474 | Koretz | Jun 2005 | A1 |
20050125056 | Deacon et al. | Jun 2005 | A1 |
20050128432 | Altmann | Jun 2005 | A1 |
20050195364 | Dai | Sep 2005 | A1 |
20050203619 | Altmann | Sep 2005 | A1 |
20050251254 | Brady et al. | Nov 2005 | A1 |
20050267575 | Nguyen et al. | Dec 2005 | A1 |
20060009816 | Fang et al. | Jan 2006 | A1 |
20060030938 | Altmann | Feb 2006 | A1 |
20060034003 | Zalevsky | Feb 2006 | A1 |
20060055877 | Yanari | Mar 2006 | A1 |
20060055883 | Morris et al. | Mar 2006 | A1 |
20060066808 | Blum et al. | Mar 2006 | A1 |
20060068453 | Altieri | Mar 2006 | A1 |
20060098162 | Bandhauer et al. | May 2006 | A1 |
20060098163 | Bandhauer et al. | May 2006 | A1 |
20060109421 | Ye et al. | May 2006 | A1 |
20060116763 | Simpson | Jun 2006 | A1 |
20060116764 | Simpson | Jun 2006 | A1 |
20060116765 | Blake et al. | Jun 2006 | A1 |
20060176572 | Fiala | Aug 2006 | A1 |
20060203198 | Liang | Sep 2006 | A1 |
20060238702 | Glick et al. | Oct 2006 | A1 |
20060244904 | Hong et al. | Nov 2006 | A1 |
20060244906 | Piers et al. | Nov 2006 | A1 |
20060244916 | Guillon | Nov 2006 | A1 |
20060274268 | Andino et al. | Dec 2006 | A1 |
20060279699 | Liang | Dec 2006 | A1 |
20060279700 | Liang | Dec 2006 | A1 |
20070052920 | Stewart et al. | Mar 2007 | A1 |
20070052927 | Noda et al. | Mar 2007 | A1 |
20070129803 | Cumming et al. | Jun 2007 | A1 |
20070171362 | Simpson et al. | Jul 2007 | A1 |
20070182924 | Hong et al. | Aug 2007 | A1 |
20070195265 | Dreher et al. | Aug 2007 | A1 |
20070211214 | Dai | Sep 2007 | A1 |
20070268453 | Hong et al. | Nov 2007 | A1 |
20070285617 | Mills et al. | Dec 2007 | A1 |
20080018910 | Neal et al. | Jan 2008 | A1 |
20080030677 | Simpson | Feb 2008 | A1 |
20080033546 | Liang | Feb 2008 | A1 |
20080161913 | Brady et al. | Jul 2008 | A1 |
20080161914 | Brady et al. | Jul 2008 | A1 |
20080198331 | Azar et al. | Aug 2008 | A1 |
20080231809 | Haigis | Sep 2008 | A1 |
20080269642 | Deacon et al. | Oct 2008 | A1 |
20080273169 | Blum et al. | Nov 2008 | A1 |
20080291393 | Menezes | Nov 2008 | A1 |
20090000628 | Somani et al. | Jan 2009 | A1 |
20090012609 | Geraghty et al. | Jan 2009 | A1 |
20090036980 | Norrby et al. | Feb 2009 | A1 |
20090062911 | Bogaert | Mar 2009 | A1 |
20090164008 | Hong et al. | Jun 2009 | A1 |
20090168019 | Tuan | Jul 2009 | A1 |
20090187242 | Weeber et al. | Jul 2009 | A1 |
20090210054 | Weeber et al. | Aug 2009 | A1 |
20090231546 | Dai | Sep 2009 | A1 |
20090234448 | Weeber et al. | Sep 2009 | A1 |
20090268155 | Weeber | Oct 2009 | A1 |
20090268158 | Weeber | Oct 2009 | A1 |
20090275929 | Zickler | Nov 2009 | A1 |
20090279048 | Hong et al. | Nov 2009 | A1 |
20090281552 | Hiramatsu et al. | Nov 2009 | A1 |
20090292354 | Gontijo et al. | Nov 2009 | A1 |
20090295295 | Shannon et al. | Dec 2009 | A1 |
20090303465 | Clements et al. | Dec 2009 | A1 |
20090323020 | Zhao et al. | Dec 2009 | A1 |
20100016961 | Hong et al. | Jan 2010 | A1 |
20100016965 | Hong et al. | Jan 2010 | A1 |
20100082017 | Zickler et al. | Apr 2010 | A1 |
20100097569 | Weeber et al. | Apr 2010 | A1 |
20100130888 | Deacon et al. | May 2010 | A1 |
20100161048 | Schaper, Jr. | Jun 2010 | A1 |
20100179793 | Chernyak et al. | Jul 2010 | A1 |
20100220185 | Vertoprakhov et al. | Sep 2010 | A1 |
20100234833 | Dai | Sep 2010 | A1 |
20100315589 | Portney | Dec 2010 | A1 |
20110080562 | Iizuka et al. | Apr 2011 | A1 |
20110149236 | Weeber | Jun 2011 | A1 |
20110166652 | Bogaert et al. | Jul 2011 | A1 |
20110205486 | Zhao | Aug 2011 | A1 |
20110211163 | Meuse et al. | Sep 2011 | A1 |
20110270596 | Weeber | Nov 2011 | A1 |
20120140166 | Zhao | Jun 2012 | A1 |
20120238904 | Manns et al. | Sep 2012 | A1 |
20120249955 | Sarver et al. | Oct 2012 | A1 |
20120310337 | Hacker et al. | Dec 2012 | A1 |
20130050637 | Roffman et al. | Feb 2013 | A1 |
20130226294 | Van Der Mooren et al. | Aug 2013 | A1 |
20130307965 | Widman et al. | Nov 2013 | A1 |
20130314669 | Levin et al. | Nov 2013 | A1 |
20130345807 | Olsen et al. | Dec 2013 | A1 |
20140016088 | De Rossi et al. | Jan 2014 | A1 |
20140135919 | Gontijo et al. | May 2014 | A1 |
20140160436 | Kasthurirangan et al. | Jun 2014 | A1 |
20140176904 | Lai | Jun 2014 | A1 |
20140268042 | Bor et al. | Sep 2014 | A1 |
20140293426 | Dobschal | Oct 2014 | A1 |
20140320805 | Wilzbach et al. | Oct 2014 | A1 |
20150062529 | Kasthurirangan et al. | Mar 2015 | A1 |
20150138350 | Videcoq | May 2015 | A1 |
20150250583 | Rosen et al. | Sep 2015 | A1 |
20150320547 | Rosen | Nov 2015 | A1 |
20150359625 | Argal et al. | Dec 2015 | A1 |
20150362746 | Skudder et al. | Dec 2015 | A1 |
20150379348 | Whritenor et al. | Dec 2015 | A1 |
20160157997 | Gerlach et al. | Jun 2016 | A1 |
20160299355 | Biemold et al. | Oct 2016 | A1 |
20160335474 | Santos-Villalobos | Nov 2016 | A1 |
20170189233 | Dewey | Jul 2017 | A1 |
Number | Date | Country |
---|---|---|
8107675 | Jul 1981 | DE |
3439551 | Apr 1986 | DE |
102005022683 | Nov 2006 | DE |
226400 | Jun 1987 | EP |
227357 | Jul 1987 | EP |
0343067 | Nov 1989 | EP |
0457553 | Nov 1991 | EP |
681198 | Nov 1995 | EP |
0538126 | Sep 1996 | EP |
0810427 | Dec 1997 | EP |
0926531 | Jun 1999 | EP |
949529 | Oct 1999 | EP |
957331 | Nov 1999 | EP |
1424049 | Jun 2004 | EP |
1857077 | Nov 2007 | EP |
1310267 | Jan 2008 | EP |
1424049 | Jun 2009 | EP |
2631891 | Aug 2013 | EP |
3059575 | Aug 2016 | EP |
2745711 | Sep 1997 | FR |
2433782 | Jul 2007 | GB |
2488802 | Sep 2012 | GB |
8603961 | Jul 1986 | WO |
9222264 | Dec 1992 | WO |
9303409 | Feb 1993 | WO |
9507487 | Mar 1995 | WO |
9856315 | Dec 1998 | WO |
9905499 | Feb 1999 | WO |
0019906 | Apr 2000 | WO |
0111418 | Feb 2001 | WO |
0135868 | May 2001 | WO |
0154569 | Aug 2001 | WO |
0163344 | Aug 2001 | WO |
0182839 | Nov 2001 | WO |
0185016 | Nov 2001 | WO |
0189424 | Nov 2001 | WO |
0221194 | Mar 2002 | WO |
02074210 | Sep 2002 | WO |
03009053 | Jan 2003 | WO |
04028356 | Apr 2004 | WO |
2004034129 | Apr 2004 | WO |
2004053568 | Jun 2004 | WO |
2004079637 | Sep 2004 | WO |
2004090611 | Oct 2004 | WO |
2004096014 | Nov 2004 | WO |
05019906 | Mar 2005 | WO |
2005079546 | Sep 2005 | WO |
06025726 | Mar 2006 | WO |
2006032263 | Mar 2006 | WO |
2006047698 | May 2006 | WO |
06060477 | Jun 2006 | WO |
2006060480 | Jun 2006 | WO |
2007067872 | Jun 2007 | WO |
2007092948 | Aug 2007 | WO |
2007133384 | Nov 2007 | WO |
2007142981 | Dec 2007 | WO |
2008045847 | Apr 2008 | WO |
2008083283 | Jul 2008 | WO |
2009020963 | Feb 2009 | WO |
2009029515 | Mar 2009 | WO |
2009076670 | Jun 2009 | WO |
2009105567 | Aug 2009 | WO |
2009137491 | Nov 2009 | WO |
2010009254 | Jan 2010 | WO |
2010009257 | Jan 2010 | WO |
2010028654 | Mar 2010 | WO |
2012052585 | Apr 2012 | WO |
2012074742 | Jun 2012 | WO |
2012083143 | Jun 2012 | WO |
2012085917 | Jun 2012 | WO |
2012154597 | Nov 2012 | WO |
2012166797 | Dec 2012 | WO |
2015022215 | Feb 2015 | WO |
2016032397 | Mar 2016 | WO |
2016087914 | Jun 2016 | WO |
2016123167 | Aug 2016 | WO |
Entry |
---|
Partial International Search Report for Application No. PCT/IB2017/001417, dated Feb. 9, 2018, 10 pages. |
Einighammer H.J., “The Individual Virtual Eye”, Dissertation, 2008, 157 pages. |
Abelman H., et al. “Tolerance and Nature of Residual Refraction in Symmetric Power Space as Principal Lens Powers and Meridians Change,” Computational and Mathematical Methods in Medicine, Article ID 492383, 2014, vol. 2014, pp. 1-12. |
Alfonso J.F., et al., “Prospective Study of the Acri.LISA Bifocal Intraocular Lens,” Journal of Cataract Refractive Surgery, Nov. 2007, vol. 33 (11), pp. 1930-1935. |
Alio J.L., et al., “Phakic Anterior Chamber Lenses for the Correction of Myopia: A 7-Year Cumulative Analysis of Complications in 263 Cases,” Ophthalmology, Mar. 1999, vol. 106 (3), pp. 458-466. |
Apple D.J., et al., “Anterior Chamber Lenses Part 1: Complications and Pathology and a Review of Designs,” Journal of Cataract Refractive Surgery, Mar. 1987, vol. 13 (2), pp. 157-174. |
Apple D.J., et al., Eds., “Intraocular Lenses: Evolution, Designs, Complications and Pathology,” in: New Concepts in Intraocular Lens Implantation, Williams & Wilkins publisher, Jan. 1989, vol. 22 (36), pp. 205-221. |
Apple D.J., et al., Eds., “Intraocular Lenses: Evolution, Designs, Complications and Pathology,” in: New Concepts in Intraocular Lens Implantation, Williams & Wilkins publisher, Jan. 1989, vol. 36 (1), pp. 21-36. |
Baikoff G., et al., “Angle-fixated Anterior Chamber Phakic Intraocular Lens for Myopia 7 to -19 Diopters,” Journal of Refractive Surgery, May-Jun. 1998, vol. 14 (3), pp. 282-292. |
Baumeister M., et al., “Tilt and Decentration of Spherical and Aspheric Intraocular Lenses: Effect on Higher-Order Aberrations,” Journal of Cataract & Refractive Surgery, 2009, vol. 35 (6), pp. 1006-1012. |
Brainard D.H., The Psychophysics Toolbox, Spatial Vision, vol. 10, pp. 433-436. |
Brown W.L., “Revisions to Tolerances in Cylinder Axis and in Progressive Addition Lens Power in ANSI Z80.1-2005,” Optometry, 2006, vol. 77 (7), pp. 343-349. |
Canovas C., et al., “Customized Eye Models for Determining Optimized Intraocular Lenses Power,” Biomedical Optics Express, Jun. 1, 2011, vol. 2 (6), pp. 1649-1662. |
Canovas C., et al., “Hybrid Adaptive-Optics Visual Simulator,” Optical Letters, Jan. 15, 2010, vol. 35 (2), pp. 196-198. |
Cheng X., et al., “Predicting Subjective Judgment of Best Focus with Objective Image Quality Metrics,” Journal of Vision, Apr. 2004, vol. 4 (4), pp. 310-321. |
CILCO Advertisement Brochure, Oct. 1982, 3 pages. |
Cohen A.L., “Practical Design of a Bifocal Hologram Contact Lens or Intraocular Lens,” Applied Optics, Jul. 1, 1992, vol. 31 (19), pp. 3750-3754. |
De Almeida M.S., et al., “Different Schematic Eyes and their Accuracy to the in Vivo Eye: A Quantitative Comparison Study,” Brazilian Journal of Physics, Jun. 2007, vol. 37 (2A), 10 pages. |
Diffractive Lenses for Extended Depth of Focus and Presbyopic Correction, Presentation from Wavefront Congress held on Feb. 15, 2008, Rochester, New York. |
Doskolovich L.L., et al., “Special Diffractive Lenses,” Lens and Optical Systems Design, Apr. 1992, vol. 1780, pp. 393-402. |
Gobbi P.G., et al., “Far and Near Visual Acuity with Multifocal Intraocular Lenses in an Optomechanical Eye Model with Imaging Capability,” Journal of Cataract and Refractive Surgery, 2007, vol. 33 (6), pp. 1082-1094. |
Gobbi P.G., et al., “Optomechanical Eye Model with Imaging Capabilities for Objective Evaluation of Intraocular Lenses,” Journal of Cataract and Refractive Surgery, 2006, vol. 32 (4), pp. 643-651. |
Hill W., et al., “Monte Carlo Simulation of Expected Outcomes with the Acrysof Toric Intraocular Lens,” BMC Ophthalmology, Oct. 2008, vol. 8, pp. 22. |
Kim J.H., et al., “The Analysis of Predicted Capsular Bag Diameter using Modified Model of Capsule Measuring Ring in Asians,” Clinical and Experimental Ophthalmology, Apr. 2008, vol. 36 (3), pp. 238-244. |
Kim M.J., et al., “Objective Evaluation of Through-Focus Optical Performance of Presbyopia-Correcting Intraocular Lenses Using an Optical Bench System,” Journal of Cataract and Refractive Surgery, 2011, vol. 37 (7), pp. 1305-1312. |
Klein S.A., “Optimal Corneal Ablation for Eyes with Arbitrary Hartmann-Shack Aberrations,” Journal of the Optical Society of America A, 1998, vol. 15 (9), pp. 2580-2588. |
Liang J., et al, “Objective Measurement of Wave Aberrations of the Human Eye With the Use of a Hartmann-Shack Wave-Front Sensor,” Journal of the Optical Society of America, 1994, vol. 11 (7), pp. 1949-1957. |
Liou H.L., et al., “Anatomically Accurate, Finite Model Eye for Optical Modeling,” Journal of Optical Society of America, Aug. 1997, vol. 14 (8), pp. 1684-1695. |
Liou H.L., et al., “The Prediction of Spherical Aberration with Schematic Eyes,” Ophthalmic and Physiological Optics, Jan. 1996, vol. 16 (4), pp. 348-354. |
Marinho A., “Results are Encouraging for Phakic IOLs, but More Work is needed,” Refractive Surgery, Feb. 2000, p. 12, 15. |
Marsack J.D., et al., “Metrics of Optical Quality Derived from Wave Aberrations Predict Visual Performance,” Journal of Vision, Apr. 2004, vol. 4 (4), pp. 322-328. |
Menapace R., “The Capsular Tension Rings,” Journal of Cataract & Refractive Surgery, Dec. 10, 2008, Chap. 3, pp. 27-44. |
Mencucci R., et al., “Clinical outcomes and rotational stability of a 4-haptic toric intraocular lens in myopic eyes,” Journal of Cataract & Refractive Surgery, Sep. 2014, vol. 40 (9), pp. 1479-1487. |
Monsoriu J.A., et al., “Devil's Lenses,” Optics Express, Oct. 17, 2007, vol. 15 (21), pp. 13858-13864. |
Navarro R., et al., “Accommodation-Dependent Model of the Human Eye with Aspherics,” Journal of the Optical Society of America, Aug. 1985, vol. 2 (8), pp. 1273-1281. |
Nio Y.K., et al., “Effect of Intraocular Lens Implantation on Visual Acuity, Contrast Sensitivity, and Depth of Focus,” Journal of Cataract and Refractive Surgery, Nov. 2003, vol. 29 (11), pp. 2073-2081. |
Norrby S., et al., “Model Eyes for Evaluation of Intraocular Lenses,” Applied Optics, Sep. 7, 2007, vol. 46 (26), pp. 6595-6605. |
Olsen T., “Simple Method to Calculate the Surgically Induced Refractive Change,” Journal of Cataract & Refractive Surgery, Mar. 1993, vol. 19 (2), pp. 319-320. |
Peli E., et al., “Appearance of Images Through a Multifocal Intraocular Lens,” Journal of the Optical Society of America, 2001, vol. 18 (2), pp. 302-309. |
Piers P.A., et al., “Eye Models for the Prediction of Contrast Vision in Patients with New Intraocular Lens Designs,” Optics Letters, Apr. 1, 2004, vol. 29 (7), pp. 733-735. |
Piers P.A., et al., “Theoretical Comparison of Aberration-Correcting Customized and Aspheric Intraocular Lenses,” Journal of Refractive Surgery, Apr. 2007, vol. 23 (4), pp. 374-384. |
Praeger D.L., “Praeger Technique for the Insertion of the Copeland Radial IOL Posterior Chamber Placement,” Copeland Lens, 1982, 7 pages. |
Siedlecki D., et al., “Radial Gradient index Intraocular Lens: a Theoretical Model,” Journal of Modern Optics, Feb. 20-Mar. 10, 2008, vol. 55 (4-5), pp. 639-647. |
Strenn K., et al., “Capsular bag Shrinkage after Implantation of an Open-Loop Silicone Lens and a Poly(methyl methacrylate) Capsule Tension Ring,” Journal of Cataract and Refractive Surgery, Dec. 1997, vol. 23 (10), pp. 1543-1547. |
Tehrani M., et al., “Capsule Measuring Ring to Predict Capsular Bag Diameter and Follow its Course after Foldable Intraocular Lens Implantation,” Journal of Cataract Refractive Surgery, Nov. 2003, vol. 29 (11), pp. 2127-2134. |
Terwee T., et al., “Visualization of the Retinal Image in an Eye Model With Spherical and Aspheric, Diffractive, and Refractive Multifocal Intraocular Lenses,” Journal of Refractive Surgery, Mar. 2008, vol. 24 (3), pp. 223-232. |
Van Den Berg T.J., “Analysis of Intraocular Straylight, Especially in Relation to Age,” Optometry and Vision Science, Feb. 1995, vol. 72 (2), pp. 52-59. |
Van Meeteren A., “Calculations on the Optical Modulation Transfer Function of the Human Eye for White Light,” Optica Acta, May 1974, vol. 21 (5), pp. 395-412. |
Vass C., et al., “Prediction of Pseudophakic Capsular bag Diameter based on Biometric Variables,” Journal of Cataract and Refractive Surgery, Oct. 1999, vol. 25 (10), pp. 1376-1381. |
Villegas E.A., et al., “Correlation between Optical and Psychophy, Sical Parameters as a Function of Defocus,” Optometry and Vision Science, Jan. 1, 2002, vol. 79 (1), pp. 60-67. |
Abrahamsson M., et al., “Impairment of Contrast Sensitivity Function (CSF) as a Measure of Disability Glare,” Investigative Ophthalmology & Visual Science, Jul. 1986, vol. 27 (7), pp. 1131-1136. |
Aslam, T.M., et al., “Development of a Forced Choice Photographic Questionnaire for Photic Phenomena and Its Testing—Repeatability, Reliability and Validity,” Ophthalmologica, Nov.-Dec. 2004, vol. 218 (6), pp. 402-410. |
Beer J.M., et al., “Lasers' Spectral and Temporal Profile Can Affect Visual Glare Disability,” Aviation, Space, and Environmental Medicine, Dec. 2012, vol. 83 (12), pp. 1135-1144. |
Calatayud A., et al., “Imaging Quality of Multifocal Intraocular Lenses: Automated Assessment Setup,” Ophthalmic and Physiological Optics, Jul. 2013, vol. 33 (4), pp. 420-426. |
Fernandez E.J., et al., “Adaptive Optics Visual Simulator,” Journal of Refractive Surgery, 2002, vol. 18 (5), pp. 5634-S638. |
Guirao A., et al., “Corneal Wave Aberration from Videokeratography: Accuracy and Limitations of the Procedure,” Journal of the Optical Society of America, 2000, vol. 17 (6), pp. 955-965. |
Jaeken B., et al., “Peripheral Aberrations in the Human Eye for Different Wavelengths: Off-Axis Chromatic Aberration,” Journal of the Optical Society of America A, Sep. 2011, vol. 28 (9), pp. 1871-1879. |
Javitt J.C., et al., “Validity and Reliability of the Cataract TyPE Spec: an Instrument for Measuring Outcomes of Cataract Extraction,” American Journal of Ophthalmology, Aug. 2003, vol. 136 (2), pp. 285-290. |
Jendritza B.B., et al., “Wavefront-Guided Excimer Laser Vision Correction after Multifocal IOL Implantation,” Journal of Refractive Surgery, Mar. 2008, vol. 24 (3), pp. 274-279. |
Johnson C.A., “Psychophysical Factors that Have Been Applied to Clinical Perimetry,” Vision Research, Sep. 2013, vol. 90, pp. 25-31. |
Lesmes L.A., et al., “Bayesian Adaptive Estimation of the Contrast Sensitivity Function: the Quick CSF Method,” Journal of Vision, Mar. 2010, vol. 10 (3) 17, pp. 1-21. |
Morlock, R., et al., “Patient-Reported Spectacle Independence Questionnaire (PRSIQ): Development and Validation,” American Journal of Ophthalmology, Jun. 2017, vol. 178, pp. 101-114. |
Ortiz, C., et al., “Quantification and Monitoring of Visual Disturbances for patients with cataracts using Halo v1.0 software,” Department of Optics, Laboratory of Vision Sciences and Applications, University of Granada, IWBBIO 2013, Mar. 20, 2013, XP055596332, Proceedings, 8 Pages. |
Rosen R.,et al., “A Bayesian Method Using through Focus Visual Acuity to Predict Rates of Spectacle Wear for Pseudophakic patients,” Investigative Ophthalmology & Visual Science, Jul. 2018, vol. 59 (9), pp. 1075, ARVO Annual Meeting Abstract, Retrieved from the Internet: (URL: https://iovs.arvojournals.org/article.aspx?articleid=2693341&resultClick=1). |
Vitale S., et al., “The Refractive Status and Vision Profile: A Questionnaire to Measure Vision-Related Quality of Life in Persons with Refractive Error,” Ophthalmology, Aug. 2000, vol. 107 (8), pp. 1529-1539. |
Weeber H.A., et al., “Influence of Corneal Aberrations on Dysphotopsia with Multifocal IOLs,” ARVO, 2011, Abstract. |
Weeber H.A., et al., “Influence of Corneal Aberrations on Dysphotopsia with Multifocal IOLs,” RD3115, 2011. |
Weeber H.A., et al., “Optical and Visual Performance of Patient Populations Implanted with Monofocal and Multifocal IOLs in the Presence of Defocus,” Investigative Ophthalmology & Visual Science, 2010, vol. 51, E-Abstract 5751. |
Weeber H.A., et al., “Population-based Visual Acuity in the Presence of Defocus Well Predicted by Classical Theory,” Journal of Biomedical Optics, 2010, vol. 15 (4), pp. 040509. |
Weeber H.A., et al., “Theoretical Performance of Intraocular Lenses Correcting Both Spherical and Chromatic Aberration,” Journal of Refractive Surgery, 2012, vol. 28 (1), pp. 48-52. |
Number | Date | Country | |
---|---|---|---|
20180153681 A1 | Jun 2018 | US |
Number | Date | Country | |
---|---|---|---|
62412738 | Oct 2016 | US |